State Street Corporation 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 09:45 am Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | STATE STREET CORP STT | 2,470,813 3.080% | -977,211 (-28.34%) | Filing |
| 2023-02-03 09:54 am Sale | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | STATE STREET CORP STT | 3,448,024 5.100% | -482,893 (-12.28%) | Filing |
| 2022-07-11 1:36 pm Sale | 2022-06-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | STATE STREET CORP STT | 3,930,917 5.940% | -2,547,905 (-39.33%) | Filing |
| 2022-01-10 10:29 am Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | STATE STREET CORP STT | 6,478,822 11.080% | 6,478,822 (New Position) | Filing |